DexCom, Inc. DXCM

Healthcare — Medical Devices

86.62 (0.85) (0.97%) as of 25 Sep

Market cap: $33.0B
P/E: 33.4×

Follow DXCM

S&P 500 Member Cash Flow Champion (3y) Insider Buys (last 12m)

Indexes indicate stock being part of an index,

Growth Flags show if company had growth for consecutive years,

Insider Buys alert about insiders buying in the last 12 month

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16
P/E ratio	30.87	52.90	87.30	130.38	281.07	71.65	200.70	0.00	0.00	0.00
P/S ratio	5.56	7.59	13.12	15.35	21.21	18.11	13.50	10.24	6.97	8.49
P/FCF ratio	24.04	48.53	92.82	146.62	19.10	126.15	148.17	188.35	192.52	9,737.73
P/Operating CF	88.09	101.56	355.63	337.18	490.90	202.86	138.69	313.54	121.49	366.08
P/B ratio	9.43	14.56	22.97	20.96	25.43	19.10	22.58	15.93	11.93	17.16
Price to Tangible BV	9.77	15.49	24.89	23.11	26.18	19.54	23.07	16.39	12.29	17.87
EV/Sales	5.42	7.29	13.08	15.19	20.92	17.58	13.19	9.88	6.66	8.28
EV/EBITDA	21.73	35.97	60.44	80.77	139.25	92.39	101.93	0.00	0.00	0.00
EV/Operating CF	17.55	29.73	63.28	66.00	115.74	71.21	61.91	82.73	52.02	84.47
EV/FCF	23.47	46.64	92.53	145.03	18.83	122.45	144.75	181.69	184.08	9,494.53
Quick Ratio	1.50	1.22	2.38	1.72	4.50	5.11	5.05	7.25	4.92	2.20
Current Ratio	1.88	1.47	2.84	1.99	5.11	5.58	5.47	7.64	5.36	2.73
Net Debt/EBITDA	(0.65)	(1.64)	(0.37)	(0.89)	(1.98)	(2.79)	(2.41)	2.39	8.37	2.41
Debt/Assets	19.57%	19.08%	38.86%	36.54%	40.60%	39.25%	44.83%	52.73%	36.23%	1.49%
Debt/Equity	0.45	0.59	1.18	0.92	0.98	0.92	1.22	1.52	0.78	0.02
Asset Turnover	0.73	0.63	0.62	0.56	0.53	0.58	0.68	0.73	1.10	1.65
Operating CF/Net income	1.72	1.72	1.38	1.96	2.04	0.87	3.11	(0.97)	(1.83)	(0.86)
Capex/Depreciation	(1.44)	(1.65)	(1.27)	(2.34)	22.32	(2.97)	(3.70)	(2.31)	(4.10)	(3.71)
Interest Coverage	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ROE	34.50%	27.63%	25.78%	16.35%	11.21%	40.58%	13.08%	(23.48%)	(14.28%)	(25.98%)
ROA	13.04%	9.04%	9.29%	6.61%	4.70%	16.44%	4.69%	(9.01%)	(7.68%)	(18.88%)
ROIC	28.66%	49.33%	21.00%	14.86%	12.65%	23.31%	21.03%	(40.43%)	(13.39%)	(24.04%)
Return on Tangible Assets	24.24%	21.27%	13.60%	11.83%	5.76%	16.53%	5.24%	(7.66%)	(6.68%)	(22.86%)
Average Days of Receivables	95.21	91.02	98.13	89.48	76.67	81.18	70.80	80.21	68.22	64.75
Research and Development Expense of Revenue	12.85%	13.70%	13.96%	16.64%	24.68%	18.68%	18.53%	40.46%	25.80%	27.23%
Selling, General and Administrative Expense of Revenue	27.69%	31.88%	32.73%	34.63%	33.10%	32.09%	34.94%	41.95%	48.60%	49.92%
Intangible Assets out of Total Assets	0.02	0.02	0.03	0.04	0.01	0.01	0.01	0.01	0.01	0.03
Share Based Compensation of Revenue	3.42%	4.23%	4.16%	4.35%	4.63%	6.20%	6.96%	9.88%	14.78%	19.33%
Graham Net Nets	0.02	0.00	0.00	0.01	0.02	0.03	0.02	0.04	0.05	0.03
Graham Number	18.45	13.29	13.04	10.41	7.53	11.85	3.85	0.00	0.00	0.00
Earnings Yield	3.24%	1.89%	1.15%	0.77%	0.36%	1.40%	0.50%	(1.20%)	(1.02%)	(1.34%)
Free Cash Flow Yield	4.16%	2.06%	1.08%	0.68%	5.24%	0.79%	0.67%	0.53%	0.52%	0.01%
Revenue per Share	11.95	10.25	9.38	7.47	6.33	5.10	4.05	2.92	2.08	1.71
Operating CF per Share	3.69	2.51	1.94	1.72	1.14	1.26	0.86	0.35	0.27	0.17
Capex per Share	(0.93)	(0.91)	(0.61)	(0.94)	5.89	(0.53)	(0.49)	(0.19)	(0.19)	(0.17)
Free Cash Flow per Share	2.76	1.60	1.33	0.78	7.03	0.73	0.37	0.16	0.08	0.00
Cash per Share	5.12	6.55	7.06	6.31	7.06	7.17	4.21	3.93	1.59	0.37
Shareholders Equity per Share	7.04	5.34	5.36	5.47	5.28	4.84	2.42	1.88	1.21	0.85
Interest Debt per Share	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Book value per Share	7.04	5.34	5.36	5.47	5.28	4.84	2.42	1.88	1.21	0.85
Free Cash Flow	1,077.20	630.70	511.90	304.70	2,719.60	276.60	134.50	56.10	26.00	0.50
Working Capital	1,890.80	1,369.40	2,869.90	1,829.50	2,963.60	2,810.70	1,609.20	1,477.10	605.80	177.60
Capital Expenditures	(363.50)	(358.80)	(236.60)	(364.80)	2,277.10	(199.00)	(180.00)	(67.10)	(66.00)	(55.70)
Net Current Asset Value	439.40	(80.50)	230.00	408.90	793.20	960.80	457.00	446.80	260.00	161.00
EV/EBIT	27.73	49.02	79.25	112.96	192.68	113.08	136.82	0.00	0.00	0.00
Capex to Sales	0.08	0.09	0.07	0.13	(0.93)	0.10	0.12	0.07	0.09	0.10
Net Profit Margin	17.94%	14.29%	14.95%	11.73%	8.86%	28.53%	6.85%	(12.32%)	(6.99%)	(11.44%)
Price to Operating Income	28.40	51.02	79.49	114.20	195.40	116.50	140.05	0.00	0.00	0.00
Other line items
Depreciation/Fixed assets	0.16	0.16	0.17	0.15	0.13	0.13	0.15	0.16	0.11	0.14
Cash ROIC	(1.99%)	(5.92%)	(5.05%)	(5.89%)	(5.30%)	(0.64%)	(0.19%)	(1.96%)	(4.14%)	(12.87%)
Accounts Receivable Turnover	4.20	4.07	4.29	4.74	5.19	5.39	5.75	5.72	6.09	6.52
Accounts Payable Turnover	1.05	1.09	1.19	1.39	1.46	1.75	2.70	3.14	2.92	3.64
Inventory Turnover	3.18	2.89	3.08	3.09	2.59	3.65	5.72	6.35	5.00	4.84
Average Days of Payables	381.46	362.78	368.31	320.60	272.32	271.58	171.88	146.02	140.58	127.53
Days of Inventory on Hand	123.45	124.18	153.18	109.03	169.81	132.49	80.31	70.18	72.87	85.02
Average Receivables	1,110.90	989.80	843.60	613.80	471.40	357.40	256.50	180.50	118.00	87.90
Average Payables	1,764.55	1,465.30	1,123.65	737.40	527.05	368.75	201.75	117.15	77.65	53.50
Average Inventory	585.85	551.10	433.15	332.00	296.00	177.25	95.25	57.95	45.30	40.30
Average Assets	6,412.20	6,374.50	5,828.10	5,162.50	4,611.90	3,342.75	2,155.50	1,410.05	653.45	347.40
Average Common Equity	2,424.30	2,085.60	2,100.20	2,086.95	1,934.30	1,354.55	772.95	541.35	351.60	252.50

Show all line items

Columns are period end dates

Powerpack

Full quarterly history

Analyst estimates

Unlimited screener

Unlimited Excel

Unlimited follows

DexCom, Inc. DXCM